Martin Marietta Materials emerged from its July 30 earnings print with the stock lower and the Street quickly marking down its price targets — the clearest signal that the bull case heading into results did not fully materialise.
The analyst reaction has been uniformly one-directional. Every firm that moved in the days following the print lowered its target, with no upgrades or new initiations to offset the drift. UBS cut to $715 from $739 while holding Buy. Citigroup moved to $690 from $737, also maintaining Buy. JP Morgan trimmed to $680 from $700 at Neutral. Wells Fargo was the most downbeat, setting $581 — barely above where the stock is now trading. The consensus mean target sits near $664, implying roughly 19% upside from the current $555.82 close, but that gap reflects a Street still broadly constructive rather than one pricing in a recovery. Ratings have not been downgraded; targets have simply been walked closer to where the stock already trades. The direction of travel is cautious.
Options positioning tells a slightly different story from the pre-earnings aggression. The put/call ratio has ticked up from the near-52-week-low of 0.22 seen before the July 30 print to 0.24 now — still well below its 20-day average of 0.28 and slightly below the mean. Call-side skew remains the dominant posture, which is notable given the stock fell nearly 8% on the day of results. Shorts are not piling in: short interest has edged up about 2.2% on the week to 4.1% of the free float, roughly 2.5 million shares, continuing a steady build from early July's 2.3 million. That is a meaningful one-month rise of about 9%, but the borrow market remains entirely uncongested. Availability is running above 1,000% of short interest — deep in the "plenty of supply" zone — and cost to borrow has actually eased 7% on the week to just 0.46%. Shorts have been adding, but they are doing so cheaply and without any sign of squeeze pressure.
The valuation picture reflects the de-rating under way. The trailing P/E has compressed to roughly 24.9x, down more than 3 points over the past month. Price-to-book is at 2.66x, off nearly 0.4 over the same period. EV/EBITDA sits near 14.6x. These are not distressed multiples for a construction-materials compounder, but they represent a meaningful step-down from where the stock was trading before the earnings disappointment. Factor scores add texture to the caution: forward EPS momentum ranks in just the 5th percentile of the universe on a 12-month basis, a stark number that suggests estimate revisions remain a headwind. The short score of 41 is steady and unremarkable — this is not a name where short-side positioning is the dominant driver.
Peer performance over the past week underscores that the sector broadly absorbed selling, not just MLM. Closest peer VMC fell about 1.2% on the week while CRH dropped 4.4% — both less severe than MLM's 4.8% decline. TTAM fared worse, down nearly 9%, while KNF saw sharp single-day selling. The prior note flagged MLM absorbing pressure more defensively than international peers; that relative resilience narrowed after the earnings miss. T. Rowe Price is the institutional holder with the most notable recent movement, adding over 1.2 million shares as of the June 30 reporting date — a substantial position build that predates the results.
The next scheduled earnings event lands October 30. Between now and then, the key variable is whether estimate revisions stabilise or continue lower — the 5th-percentile forward EPS momentum score suggests the Street is still in the process of adjusting, and how quickly that floor sets will shape whether the current discount to targets attracts fresh buyers or simply narrows as targets catch down to price.
See the live data behind this article on ORTEX.
Open MLM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
